
### [MONDO:0017841](http://purl.obolibrary.org/obo/MONDO_0017841)
**Label:** autoimmune disease with skin involvement

**Subclasses:** [MONDO:0018745](http://purl.obolibrary.org/obo/MONDO_0018745) (superficial pemphigus), [MONDO:0019557](http://purl.obolibrary.org/obo/MONDO_0019557) (Chilblain lupus), [MONDO:0019337](http://purl.obolibrary.org/obo/MONDO_0019337) (autoimmune bullous skin disease), [MONDO:0018887](http://purl.obolibrary.org/obo/MONDO_0018887) (rare cutaneous lupus erythematosus), [MONDO:0015574](http://purl.obolibrary.org/obo/MONDO_0015574) (chronic cutaneous lupus erythematosus), [MONDO:0008219](http://purl.obolibrary.org/obo/MONDO_0008219) (pemphigus vulgaris), [MONDO:0015614](http://purl.obolibrary.org/obo/MONDO_0015614) (dermatitis herpetiformis), 

**Corr. equiv. classes:** [Orphanet:79669](http://www.orpha.net/ORDO/Orphanet_79669), [Orphanet:163531](http://www.orpha.net/ORDO/Orphanet_163531), [Orphanet:90280](http://www.orpha.net/ORDO/Orphanet_90280), [Orphanet:704](http://www.orpha.net/ORDO/Orphanet_704), [OMIM:169610](http://purl.obolibrary.org/obo/OMIM_169610), [Orphanet:1656](http://www.orpha.net/ORDO/Orphanet_1656), [Orphanet:535](http://www.orpha.net/ORDO/Orphanet_535), [Orphanet:46485](http://www.orpha.net/ORDO/Orphanet_46485), 

**Class expressions from DL-Learner:**

- [HP:0100792](http://purl.obolibrary.org/obo/HP_0100792) (Acantholysis) 62.50%
- [HP:0025142](http://purl.obolibrary.org/obo/HP_0025142) (Constitutional symptom) and [HP:0200037](http://purl.obolibrary.org/obo/HP_0200037) (Skin vesicle) 62.50%
- [HP:0012531](http://purl.obolibrary.org/obo/HP_0012531) (Pain) and [HP:0200037](http://purl.obolibrary.org/obo/HP_0200037) (Skin vesicle) 62.50%
- [HP:0011276](http://purl.obolibrary.org/obo/HP_0011276) (Vascular skin abnormality) and [HP:0025142](http://purl.obolibrary.org/obo/HP_0025142) (Constitutional symptom) and [HP:0200037](http://purl.obolibrary.org/obo/HP_0200037) (Skin vesicle) 62.50%
- [HP:0011276](http://purl.obolibrary.org/obo/HP_0011276) (Vascular skin abnormality) and [HP:0012531](http://purl.obolibrary.org/obo/HP_0012531) (Pain) and [HP:0200037](http://purl.obolibrary.org/obo/HP_0200037) (Skin vesicle) 62.50%
- [HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation) and [HP:0025142](http://purl.obolibrary.org/obo/HP_0025142) (Constitutional symptom) and [HP:0200037](http://purl.obolibrary.org/obo/HP_0200037) (Skin vesicle) 62.50%
- [HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation) and [HP:0012733](http://purl.obolibrary.org/obo/HP_0012733) (Macule) and [HP:0200037](http://purl.obolibrary.org/obo/HP_0200037) (Skin vesicle) 62.50%
- [HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation) and [HP:0012531](http://purl.obolibrary.org/obo/HP_0012531) (Pain) and [HP:0200037](http://purl.obolibrary.org/obo/HP_0200037) (Skin vesicle) 62.50%
- [HP:0010783](http://purl.obolibrary.org/obo/HP_0010783) (Erythema) and [HP:0025142](http://purl.obolibrary.org/obo/HP_0025142) (Constitutional symptom) and [HP:0200037](http://purl.obolibrary.org/obo/HP_0200037) (Skin vesicle) 62.50%
- [HP:0010783](http://purl.obolibrary.org/obo/HP_0010783) (Erythema) and [HP:0012733](http://purl.obolibrary.org/obo/HP_0012733) (Macule) and [HP:0200037](http://purl.obolibrary.org/obo/HP_0200037) (Skin vesicle) 62.50%
- [HP:0010783](http://purl.obolibrary.org/obo/HP_0010783) (Erythema) and [HP:0012531](http://purl.obolibrary.org/obo/HP_0012531) (Pain) and [HP:0200037](http://purl.obolibrary.org/obo/HP_0200037) (Skin vesicle) 62.50%
- [HP:0000989](http://purl.obolibrary.org/obo/HP_0000989) (Pruritus) and [HP:0011276](http://purl.obolibrary.org/obo/HP_0011276) (Vascular skin abnormality) and [HP:0200037](http://purl.obolibrary.org/obo/HP_0200037) (Skin vesicle) 62.50%
- [HP:0000989](http://purl.obolibrary.org/obo/HP_0000989) (Pruritus) and [HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation) and [HP:0200037](http://purl.obolibrary.org/obo/HP_0200037) (Skin vesicle) 62.50%
- [HP:0000989](http://purl.obolibrary.org/obo/HP_0000989) (Pruritus) and [HP:0010783](http://purl.obolibrary.org/obo/HP_0010783) (Erythema) and [HP:0200037](http://purl.obolibrary.org/obo/HP_0200037) (Skin vesicle) 62.50%
- [HP:0000969](http://purl.obolibrary.org/obo/HP_0000969) (Edema) and [HP:0025142](http://purl.obolibrary.org/obo/HP_0025142) (Constitutional symptom) and [HP:0200037](http://purl.obolibrary.org/obo/HP_0200037) (Skin vesicle) 62.50%


